BUY Max Healthcare Institute Limited — Motilal Oswal
byMotilal OswalHorizon: NA (inferred 1 year)23 Jun 2026via ET Now (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Max Healthcare MAXHEALTH: CARE Upgrades Subsidiary Credit Rating
NewsGoogle News·9 Oct · 2w ago
13 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·1 Oct · 3w ago
Q2 FY27 results scheduled — board meets 30 Oct 2026
BSE · Board Meeting·In 5 days
Divi's Labs, TVS Motor could replace Max Healthcare, HDFC Life in NSE's March 2027 index review
NewsEt-Markets·6 Oct · 3w ago
Max Healthcare Institute among 3 F&O stocks with a sharp rise in futures open interest
NewsEt-Markets·1 Oct · 3w ago
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·23 Oct · yesterday
1 advisor has an active short-term SELL call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·13 Oct · 2w ago
Macquarie sees mid-teens earnings risk for Max Health stock
NewsGoogle News·12 Oct · 2w ago
Max Health stock hits a 52-week low as margins face pressure
NewsGoogle News·7 Oct · 2w ago
Hospital stocks Max Healthcare, Apollo Hospitals, Fortis plunge up to 7% - What is driving the stocks down?
NewsLivemint·30 Sept · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Max Healthcare Institute
- SELL — Akshay Bhagwat, JM Financial13 Oct 2026 · ~3 months · target ₹700 · Active
- SELL — Prakash Gaba5 Oct 2026 · ~2 weeks · target ₹900 · Target hit
- BUY — Goldman Sachs1 Oct 2026 · ~1 year · target ₹1,200 · Active
- BUY — Emkay Global1 Oct 2026 · ~1 year · target ₹1,150 · Active
- SELL — Nagaraj Shetty, HDFC Securities30 Sept 2026 · ~3 months · target ₹870 · Target hit
More from Motilal Oswal
- BUY Colgate Palmolive (India)22 Oct 2026 · ~1 year · target ₹2,000 · Active
- BUY Sapphire Foods India22 Oct 2026 · ~1 year · target ₹245 · Active
- BUY CIE Automotive India22 Oct 2026 · ~1 year · target ₹440 · Active
- BUY CREDITACCESS GRAMEEN22 Oct 2026 · ~1 year · target ₹1,450 · Active
- BUY KEI Industries22 Oct 2026 · ~1 year · target ₹5,180 · Active

